{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T17:56:44Z","timestamp":1762624604826,"version":"build-2065373602"},"reference-count":14,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.jaip.2021.01.014","type":"journal-article","created":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T05:20:18Z","timestamp":1617772818000},"page":"1658-1659","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Immediate Reactions to Cephalosporins: It is Time to Standardize the Diagnostic Essence"],"prefix":"10.1016","volume":"9","author":[{"given":"Vito","family":"Sabato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Line van der","family":"Poorten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Didier G.","family":"Ebo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2021.01.014_bib1","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1111\/all.13721","article-title":"A\u00a0EAACI drug allergy interest group survey on how European allergy specialists deal with beta-lactam allergy","volume":"74","author":"Torres","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2021.01.014_bib2","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.jaip.2018.11.023","article-title":"Drug hypersensitivity reactions documented in electronic health records within a large health system","volume":"7","author":"Wong","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2021.01.014_bib3","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/j.jaip.2019.06.001","article-title":"Cephalosporin allergy: current understanding and future challenges","volume":"7","author":"Khan","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2021.01.014_bib4","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1016\/j.jaip.2020.11.032","article-title":"Evaluating immediate reactions to cephalosporins: time is of the essence","volume":"9","author":"Romano","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2021.01.014_bib5","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/S0091-6749(99)70439-2","article-title":"Natural evolution of skin test sensitivity in patients allergic to beta-lactam antibiotics","volume":"103","author":"Blanca","year":"1999","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.01.014_bib6","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1398-9995.2006.01272.x","article-title":"A\u00a0comparison of the performance of two penicillin reagent kits in the diagnosis of beta-lactam hypersensitivity","volume":"62","author":"Romano","year":"2007","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2021.01.014_bib7","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/all.12390","article-title":"Natural evolution of skin-test sensitivity in patients with IgE-mediated hypersensitivity to cephalosporins","volume":"69","author":"Romano","year":"2014","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2021.01.014_bib8","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1111\/all.14122","article-title":"Towards a more precise diagnosis of hypersensitivity to beta-lactams\u2014an EAACI position paper","volume":"75","author":"Romano","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2021.01.014_bib9","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/j.jaip.2020.08.006","article-title":"Practical guidance for the evaluation and management of drug hypersensitivity: specific drugs","volume":"8","author":"Broyles","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2021.01.014_bib10","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.jaip.2020.08.031","article-title":"Nonirritating skin test concentrations for ceftazidime and aztreonam in patients with a documented beta-lactam allergy","volume":"9","author":"van der Poorten","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2021.01.014_bib11","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3389\/fmed.2020.00156","article-title":"Intradermal tests with drugs: an approach to standardization","volume":"7","author":"Barbaud","year":"2020","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jaip.2021.01.014_bib12","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.1016\/j.jaip.2019.05.035","article-title":"Specific IgE to cefazolin: Does it benefit diagnosis?","volume":"7","author":"Van Gasse","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2021.01.014_bib13","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.jaci.2020.10.027","article-title":"Principles, potential, and limitations of ex vivo basophil activation by flow cytometry in allergology: a narrative review","volume":"147","author":"Ebo","year":"2021","journal-title":"J Allergy Clin Immunol"},{"author":"Touati","key":"10.1016\/j.jaip.2021.01.014_bib14"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219821000702?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219821000702?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:26:43Z","timestamp":1761974803000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219821000702"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":14,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S2213219821000702"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2021.01.014","relation":{},"ISSN":["2213-2198"],"issn-type":[{"type":"print","value":"2213-2198"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immediate Reactions to Cephalosporins: It is Time to Standardize the Diagnostic Essence","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2021.01.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2020.11.032","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}